Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multi- Target Hepatocellular Carcinoma Test in Increased Risk

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Study CT/MRI Imaging
  • +2 more
  • Chandler, Arizona
  • +33 more
May 27, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic Trial in Belgium, France, United States (GNS561)

Terminated
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma, Intrahepatic
  • New York, New York
  • +4 more
Apr 25, 2022

Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

Terminated
  • Advanced Gastrointestinal (GI) Malignancies
  • +3 more
  • ADI-PEG 20 plus modified FOLFOX6
  • San Francisco, California
  • +34 more
Apr 18, 2022

Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab (Regimen 1), Tremelimumab (Regimen 2))

Recruiting
  • Hepatocellular Carcinoma
  • Los Angeles, California
  • +173 more
Mar 25, 2022

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Daly City, California
  • +130 more
Jan 5, 2022

NSCLC, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in New York (cemiplimab, Platinum Doublet)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 24, 2021

Hepatocellular Carcinoma Trial in Worldwide (HepaSphere/QuadraSphere Microspheres, PVA, lipiodol, doxorubicin)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • HepaSphere/QuadraSphere Microspheres
  • PVA, lipiodol, doxorubicin
  • Birmingham, Alabama
  • +22 more
Nov 2, 2021

Hepatocellular Carcinoma Trial in New York, Philadelphia (Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2

Recruiting
  • Hepatocellular Carcinoma
  • Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2 weeks
  • +2 more
  • New York, New York
  • +1 more
Nov 1, 2021

NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)

Recruiting
  • Non-small Cell Lung Cancer
  • Hepatocellular Carcinoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 14, 2021

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
Has Results
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Hepatocellular Carcinoma Trial in New York (Radiation Segmentectomy)

Completed
  • Hepatocellular Carcinoma
  • Radiation Segmentectomy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2021

Direct Acting Antiviral-Post Authorization Safety Study

Completed
  • Hepatitis C
  • Hepatocellular Carcinoma
    • Phoenix, Arizona
    • +61 more
    Jul 1, 2021

    Hepatocellular Carcinoma, Liver Cancer, Hepatoma Trial in New York (Bead Block microspheres, Bead + Dox Arm)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Bead Block microspheres
    • Bead + Dox Arm
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 30, 2021

    Hepatocellular Carcinoma Trial in Worldwide (Cabozantinib tablets, Placebo tablets)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Cabozantinib tablets
    • Placebo tablets
    • Corona, California
    • +103 more
    Apr 8, 2021

    Hepatocellular Carcinoma Trial in Worldwide (TheraSphere®, Sorafenib)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • Chicago, Illinois
    • +18 more
    Apr 19, 2021

    Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Tucson, Arizona
    • +112 more
    Mar 12, 2021

    Hepatocellular Carcinoma Trial in United States (Enzalutamide, Enzalutamide with Sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • San Francisco, California
    • +4 more
    Mar 3, 2021

    Hepatocellular Carcinoma Trial in Chicago, New York, Winston-Salem (TheraBionic Device, Placebo Device)

    Withdrawn
    • Hepatocellular Carcinoma
    • TheraBionic Device
    • Placebo Device
    • Chicago, Illinois
    • +2 more
    Feb 23, 2021

    Hepatocellular Carcinoma, HCC Trial in New York (Magnetic Resonance Imaging)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • HCC
    • Magnetic Resonance Imaging
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 25, 2020

    Hepatocellular Carcinoma Trial in Canada, United Kingdom, United States (SGI-110)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Duarte, California
    • +23 more
    Jan 13, 2020

    The Second Multicenter Hemophilia Cohort Study

    Completed
    • Liver Decompensation
    • +2 more
      • Tucson, Arizona
      • +47 more
      Dec 14, 2019

      Hepatocellular Carcinoma Trial in Worldwide (ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol), Placebo, Best

      Completed
      • Hepatocellular Carcinoma
      • ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)
      • +2 more
      • Birmingham, Alabama
      • +72 more
      Aug 27, 2019